Results 91 to 100 of about 78,579 (196)
Российский кардиологический журнал, 2012 Aim. To identify the optimal therapeutic strategy in Functional Class (FC) I–II chronic heart failure (CHF), in accordance with the effects of different drug classes on the regulatory and adaptive status (RAS). Material and methods.
S. G. Kanorskyi +2 more
doaj
Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences
Российский кардиологический журнал, 2007 .
Yu. B. Belousov +2 more
doaj
Drug-induced Raynaud phenomenon following initiation of metoprolol succinate. [PDF]
CMAJSahoo S, Gavin MC, Cluett JL.
europepmc +1 more source
Influencing factors analysis of clinical effect of heart failure patients treated with ivabradine and metoprolol succinate and construction and validation of nomogram prediction model. [PDF]
Front Cardiovasc MedWu G +8 more
europepmc +1 more source
Development of a sustained-release microcapsule for delivery of metoprolol succinate. [PDF]
Exp Ther Med, 2017 Song L, He S, Ping Q.
europepmc +1 more source
Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy. [PDF]
Int J Med Sci, 2017 Jiang J +16 more
europepmc +1 more source
In Silico comparison between metoprolol succinate and bisoprolol on 24-hour systolic blood pressures. [PDF]
Drugs R D, 2014 Jansson SO, Malm AE, Lundström T.
europepmc +1 more source